Davis Selected Advisers Sells 52,648 Shares of Humana Inc. (NYSE:HUM)

Davis Selected Advisers decreased its stake in shares of Humana Inc. (NYSE:HUM - Free Report) by 2.3% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 2,256,909 shares of the insurance provider's stock after selling 52,648 shares during the period. Humana makes up 3.3% of Davis Selected Advisers' investment portfolio, making the stock its 11th largest holding. Davis Selected Advisers owned approximately 1.87% of Humana worth $572,600,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other large investors have also recently modified their holdings of HUM. FPC Investment Advisory Inc. bought a new stake in Humana during the fourth quarter worth about $27,000. Centricity Wealth Management LLC bought a new stake in Humana during the fourth quarter worth about $30,000. Ashton Thomas Securities LLC bought a new stake in Humana during the third quarter worth about $31,000. Atwood & Palmer Inc. boosted its stake in Humana by 64.5% during the fourth quarter. Atwood & Palmer Inc. now owns 153 shares of the insurance provider's stock worth $39,000 after acquiring an additional 60 shares in the last quarter. Finally, Kestra Investment Management LLC bought a new stake in Humana during the fourth quarter worth about $49,000. Institutional investors own 92.38% of the company's stock.

Humana Stock Performance

HUM stock traded down $0.88 during midday trading on Wednesday, reaching $249.32. 1,150,855 shares of the company's stock traded hands, compared to its average volume of 1,665,448. Humana Inc. has a 52-week low of $213.31 and a 52-week high of $406.46. The stock has a market cap of $30.08 billion, a P/E ratio of 25.06, a PEG ratio of 2.05 and a beta of 0.57. The company has a current ratio of 1.76, a quick ratio of 1.76 and a debt-to-equity ratio of 0.68. The stock's 50-day moving average is $271.67 and its 200 day moving average is $281.65.

Remove Ads

Humana (NYSE:HUM - Get Free Report) last announced its earnings results on Tuesday, February 11th. The insurance provider reported ($2.16) EPS for the quarter, beating analysts' consensus estimates of ($2.26) by $0.10. Humana had a net margin of 1.02% and a return on equity of 11.70%. As a group, analysts anticipate that Humana Inc. will post 16.47 EPS for the current year.

Humana Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Friday, April 25th. Stockholders of record on Friday, March 28th will be paid a $0.885 dividend. The ex-dividend date is Friday, March 28th. This represents a $3.54 dividend on an annualized basis and a dividend yield of 1.42%. Humana's dividend payout ratio (DPR) is presently 35.58%.

Analyst Upgrades and Downgrades

Several research firms recently commented on HUM. StockNews.com lowered shares of Humana from a "buy" rating to a "hold" rating in a research note on Wednesday, March 5th. Piper Sandler boosted their price objective on shares of Humana from $270.00 to $288.00 and gave the stock a "neutral" rating in a research note on Wednesday, January 15th. Cantor Fitzgerald reissued a "neutral" rating and set a $290.00 price objective on shares of Humana in a research note on Wednesday, February 12th. Morgan Stanley dropped their target price on shares of Humana from $301.00 to $285.00 and set an "equal weight" rating on the stock in a research note on Wednesday, February 12th. Finally, JPMorgan Chase & Co. dropped their target price on shares of Humana from $257.00 to $256.00 and set a "neutral" rating on the stock in a research note on Tuesday, February 18th. Twenty research analysts have rated the stock with a hold rating and five have assigned a buy rating to the stock. According to MarketBeat.com, Humana currently has an average rating of "Hold" and a consensus price target of $285.68.

Insider Transactions at Humana

In other news, insider Timothy S. Huval sold 3,703 shares of the stock in a transaction on Tuesday, December 31st. The shares were sold at an average price of $256.26, for a total value of $948,930.78. Following the completion of the sale, the insider now directly owns 8,181 shares of the company's stock, valued at $2,096,463.06. This represents a 31.16 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Corporate insiders own 0.32% of the company's stock.

Humana Company Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.